NO143741C - Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien - Google Patents
Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serienInfo
- Publication number
- NO143741C NO143741C NO2724/73A NO272473A NO143741C NO 143741 C NO143741 C NO 143741C NO 2724/73 A NO2724/73 A NO 2724/73A NO 272473 A NO272473 A NO 272473A NO 143741 C NO143741 C NO 143741C
- Authority
- NO
- Norway
- Prior art keywords
- prostagland
- connections
- series
- preparation
- physiologically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
- B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING
- B63B2211/00—Applications
- B63B2211/02—Oceanography
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO751726A NO751726L (de) | 1972-07-13 | 1975-05-15 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27122072A | 1972-07-13 | 1972-07-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO143741B NO143741B (no) | 1980-12-29 |
| NO143741C true NO143741C (no) | 1981-04-08 |
Family
ID=23034697
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2724/73A NO143741C (no) | 1972-07-13 | 1973-07-03 | Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien |
| NO743492A NO144830C (no) | 1972-07-13 | 1974-09-26 | Substituert cyklopentanderivat for anvendelse som mellomprodukt ved fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743492A NO144830C (no) | 1972-07-13 | 1974-09-26 | Substituert cyklopentanderivat for anvendelse som mellomprodukt ved fremstilling av en fysiologisk aktiv prostaglandinforbindelse av e- eller f-serien |
Country Status (25)
| Country | Link |
|---|---|
| JP (4) | JPS5241257B2 (de) |
| AR (2) | AR209064A1 (de) |
| AT (1) | AT367033B (de) |
| BE (1) | BE802231A (de) |
| CA (1) | CA1041495A (de) |
| CH (1) | CH593254A5 (de) |
| CS (1) | CS201027B2 (de) |
| DD (2) | DD109210A5 (de) |
| DE (1) | DE2334945A1 (de) |
| ES (4) | ES416865A1 (de) |
| FI (1) | FI57583C (de) |
| FR (1) | FR2192834B1 (de) |
| GB (1) | GB1446341A (de) |
| HU (4) | HU171156B (de) |
| IE (1) | IE37909B1 (de) |
| IL (2) | IL42691A (de) |
| IN (1) | IN138789B (de) |
| LU (1) | LU68015A1 (de) |
| NL (1) | NL7309792A (de) |
| NO (2) | NO143741C (de) |
| PH (1) | PH11461A (de) |
| SE (3) | SE7705945L (de) |
| SU (4) | SU644384A3 (de) |
| YU (1) | YU187773A (de) |
| ZA (1) | ZA734769B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
| DE2416193C2 (de) | 1974-04-03 | 1985-08-14 | Hoechst Ag, 6230 Frankfurt | Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel |
| DE2463432C2 (de) * | 1974-04-03 | 1987-06-19 | Hoechst Ag, 6230 Frankfurt, De | |
| ZA747723B (en) * | 1974-12-11 | 1976-11-24 | Pfizer | 11-desoxy-15-substituted-omega-pentanor prostaglandins |
| US4149006A (en) * | 1977-01-24 | 1979-04-10 | G. D. Searle & Co. | Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain |
| GB8329559D0 (en) * | 1983-11-04 | 1983-12-07 | Erba Farmitalia | Furyl derivatives of 16-substituted prostaglandins preparations |
| SE9002596D0 (sv) * | 1990-08-08 | 1990-08-08 | Pharmacia Ab | A method for synthesis of prostaglandin derivatives |
| US6602900B2 (en) | 1992-09-21 | 2003-08-05 | Allergan, Inc. | Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5972991A (en) * | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| KR100578616B1 (ko) * | 2004-07-23 | 2006-05-10 | 한미약품 주식회사 | Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법 |
| EP3080096A1 (de) * | 2013-12-13 | 2016-10-19 | Allergan, Inc. | Feste formen einer alpha,omega-disubstituierten dihydroxy-cyclopentyl-verbindung und verfahren zur herstellung davon und verwendung davon |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1324737A (en) * | 1970-11-02 | 1973-07-25 | Upjohn Co | Prostaglandins and the preparation thereof |
| GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
| IL50311A (en) * | 1972-06-02 | 1977-08-31 | Pfizer | Dimethyl alkoxy-2-oxoalkyl phosphonates and their preparattion |
-
1973
- 1973-07-03 ES ES416865A patent/ES416865A1/es not_active Expired
- 1973-07-03 NO NO2724/73A patent/NO143741C/no unknown
- 1973-07-05 FI FI2162/73A patent/FI57583C/fi active
- 1973-07-06 IN IN1575/CAL/73A patent/IN138789B/en unknown
- 1973-07-09 PH PH14802A patent/PH11461A/en unknown
- 1973-07-09 IL IL42691A patent/IL42691A/xx unknown
- 1973-07-10 DE DE19732334945 patent/DE2334945A1/de not_active Withdrawn
- 1973-07-11 CS CS734994A patent/CS201027B2/cs unknown
- 1973-07-12 BE BE1005234A patent/BE802231A/xx unknown
- 1973-07-12 HU HU73PI00000387A patent/HU171156B/hu unknown
- 1973-07-12 CA CA176,270A patent/CA1041495A/en not_active Expired
- 1973-07-12 HU HU73PI00000482A patent/HU172058B/hu unknown
- 1973-07-12 DD DD172243A patent/DD109210A5/xx unknown
- 1973-07-12 HU HU73PI00000481A patent/HU171946B/hu unknown
- 1973-07-12 DD DD180811*A patent/DD116459A5/xx unknown
- 1973-07-12 SU SU731948945A patent/SU644384A3/ru active
- 1973-07-12 CH CH1020673A patent/CH593254A5/xx not_active IP Right Cessation
- 1973-07-12 HU HU73PI00000480A patent/HU171158B/hu unknown
- 1973-07-13 ZA ZA734769A patent/ZA734769B/xx unknown
- 1973-07-13 AR AR249095A patent/AR209064A1/es active
- 1973-07-13 NL NL7309792A patent/NL7309792A/xx not_active Application Discontinuation
- 1973-07-13 IE IE1186/73A patent/IE37909B1/xx unknown
- 1973-07-13 AT AT0620773A patent/AT367033B/de not_active IP Right Cessation
- 1973-07-13 JP JP48079214A patent/JPS5241257B2/ja not_active Expired
- 1973-07-13 FR FR7325835A patent/FR2192834B1/fr not_active Expired
- 1973-07-13 GB GB3121773A patent/GB1446341A/en not_active Expired
- 1973-07-13 LU LU68015A patent/LU68015A1/xx unknown
- 1973-11-07 YU YU01877/73A patent/YU187773A/xx unknown
-
1974
- 1974-05-06 AR AR253775A patent/AR214383A1/es active
- 1974-09-26 NO NO743492A patent/NO144830C/no unknown
-
1975
- 1975-04-26 ES ES437037A patent/ES437037A1/es not_active Expired
- 1975-04-26 ES ES437039A patent/ES437039A1/es not_active Expired
- 1975-04-26 ES ES437038A patent/ES437038A1/es not_active Expired
- 1975-09-05 SU SU752169008A patent/SU645563A3/ru active
- 1975-09-09 SU SU7502170659A patent/SU584791A3/ru active
- 1975-09-11 SU SU752171155A patent/SU645564A3/ru active
-
1976
- 1976-08-19 IL IL50308A patent/IL50308A0/xx unknown
- 1976-11-22 JP JP14060776A patent/JPS5293753A/ja active Pending
- 1976-11-22 JP JP14060676A patent/JPS52122349A/ja active Pending
- 1976-11-22 JP JP14060576A patent/JPS5297958A/ja active Pending
-
1977
- 1977-05-20 SE SE7705945A patent/SE7705945L/xx not_active Application Discontinuation
- 1977-05-20 SE SE7705946A patent/SE7705946L/xx unknown
- 1977-05-20 SE SE7705947A patent/SE7705947L/xx not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE407579B (sv) | Forfarande for framstellning av n-fosfonometylglycin | |
| NO138335C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer | |
| NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
| NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
| SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
| SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
| NO143741C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien | |
| DE2143628B2 (de) | Kuenstliche herzkammer und herzhilfe | |
| SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
| SE416176B (sv) | Forfarande for framstellning av hogdoserade autibiotikatabletter | |
| SE7600889L (sv) | Forfarande for framstellning av deoxo- och dideoxoprostaglandin-e1 | |
| SE393111B (sv) | Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin | |
| SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
| SE396385B (sv) | Forfarande for framstellning av n-benshydryl-n'-p-hydroxibensyl-piperaziner | |
| SE399557B (sv) | Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat | |
| FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
| SE393808B (sv) | Forfarande for framstellning av isomaltit | |
| SE415355B (sv) | Forfarande for framstellning av fosfonotioureider | |
| NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
| SE391717B (sv) | Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner | |
| SE380805B (sv) | Forfarande for framstellning av oxazoler | |
| SE389862B (sv) | Forfarande for framstellning av alfa-6-deoxitetracykliner | |
| NO139086C (no) | R fremgangsmaate for fremstilling av benzensulfonylurinstoffe | |
| NO137998C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tebain- og oripavin-derivater |